Cargando…
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
BACKGROUND: We established a radiogenomic model to predict pathological complete response (pCR) in triple-negative breast cancer (TNBC) and explored the association between high-frequency mutations and drug resistance. METHODS: From April 2018 to September 2019, 112 patients who had received neoadju...
Autores principales: | Zhang, Ying, You, Chao, Pei, Yuchen, Yang, Fan, Li, Daqiang, Jiang, Yi-zhou, Shao, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171937/ https://www.ncbi.nlm.nih.gov/pubmed/35672824 http://dx.doi.org/10.1186/s12967-022-03452-1 |
Ejemplares similares
-
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
por: Jiang, Lin, et al.
Publicado: (2022) -
Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
por: Kong, Doo-Sik, et al.
Publicado: (2016) -
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
por: Su, Guan-Hua, et al.
Publicado: (2023) -
Fused feature signatures to probe tumour radiogenomics relationships
por: Xia, Tian, et al.
Publicado: (2022) -
Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy
por: Li, JunJie, et al.
Publicado: (2016)